EGFR and neoplasm: Genomic profiling of tumors has revealed specific mutations and molecular alterations that drive metastasis, including mutations in genes such as TP53, KRAS and EGFR, which have been linked to more aggressive tumor behavior and a higher risk of metastasis in several cancer types[9].